Express Pharma highlights the significant amount of H2020 funding that has helped UK Bio/Pharma companies advance their innovative technologies – Stablepharma Ltd received €50,000 to further develop its StablevaX™ technology. Full article can be found here. Through the Brexit deal struck between the UK and EU on 24 December 2021, the UK will be part […]
Read More![](https://stablepharma.com/wp-content/uploads/2021/04/shutterstock_1884612574.jpg)